Literature DB >> 15710822

Analysis of costs and benefits of the Gambian Eye Care Program.

Kevin D Frick1, Allen Foster, Momodou Bah, Hannah Faal.   

Abstract

OBJECTIVE: To estimate the net benefit of the Gambian Eye Care Program (GECP) using a limited definition of benefits from a societal perspective.
METHODS: The number of cases of blindness avoided was modeled using population projections, population-based blindness survey estimates from 1986 and 1996, and reported blindness-related mortality differences. Benefits were measured as lifetime productivity gains that resulted from the cases of blindness avoided between the surveys. Costs included all contributions to GECP between the surveys.
RESULTS: In 1996, 1658 fewer individuals were blind than would have been without GECP. The present value of costs was 1.28 US million dollars (1995 dollars). Although the net benefit between the blindness surveys was negative, the net lifetime benefit was 1.01 US million dollars (1995 dollars), yielding an internal rate of return of 10%. In the primary sensitivity analysis, assuming similar benefits to Senegalese citizens, who accounted for 30% of patients, the internal rate of return was 19%. Upper bound sensitivity analyses result in internal rates of return higher than 20%.
CONCLUSION: In one sub-Saharan African country with avoidable blindness due to cataract and eye infections, the internal rate of return of a national eye care program was substantial when using a limited definition of benefit.

Entities:  

Mesh:

Year:  2005        PMID: 15710822     DOI: 10.1001/archopht.123.2.239

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  13 in total

1.  Cost-effectiveness of glaucoma interventions in Barbados and Ghana.

Authors:  John S Wittenborn; David B Rein
Journal:  Optom Vis Sci       Date:  2011-01       Impact factor: 1.973

2.  [Global blindness].

Authors:  M Schulze Schwering
Journal:  Ophthalmologe       Date:  2007-10       Impact factor: 1.059

3.  The calculation and use of economic burden data.

Authors:  K D Frick; S M Kymes
Journal:  Br J Ophthalmol       Date:  2006-03       Impact factor: 4.638

4.  Convincing governments to act: VISION 2020 and the Millennium Development Goals.

Authors:  Hannah Faal; Clare Gilbert
Journal:  Community Eye Health       Date:  2007-12

5.  The economic impact and cost of visual impairment in Australia.

Authors:  H R Taylor; M L Pezzullo; J E Keeffe
Journal:  Br J Ophthalmol       Date:  2006-03       Impact factor: 4.638

6.  Poverty and blindness in Pakistan: results from the Pakistan national blindness and visual impairment survey.

Authors:  Clare E Gilbert; S P Shah; M Z Jadoon; R Bourne; B Dineen; M A Khan; G J Johnson; M D Khan
Journal:  BMJ       Date:  2007-12-17

Review 7.  Future trends in global blindness.

Authors:  Serge Resnikoff; Tricia U Keys
Journal:  Indian J Ophthalmol       Date:  2012 Sep-Oct       Impact factor: 1.848

Review 8.  The accomplishments of the global initiative VISION 2020: The Right to Sight and the focus for the next 8 years of the campaign.

Authors:  Peter Ackland
Journal:  Indian J Ophthalmol       Date:  2012 Sep-Oct       Impact factor: 1.848

9.  A case-control study to assess the relationship between poverty and visual impairment from cataract in Kenya, the Philippines, and Bangladesh.

Authors:  Hannah Kuper; Sarah Polack; Cristina Eusebio; Wanjiku Mathenge; Zakia Wadud; Allen Foster
Journal:  PLoS Med       Date:  2008-12-16       Impact factor: 11.069

10.  The development of a public optometry system in Mozambique: a Cost Benefit Analysis.

Authors:  Stephen Thompson; Kovin Naidoo; Geoff Harris; Luigi Bilotto; Jorge Ferrão; James Loughman
Journal:  BMC Health Serv Res       Date:  2014-09-23       Impact factor: 2.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.